Cite
APA Citation
Al-Fayoumi, S., Watson, R., O'Mahony, A., & Singer, J. (n.d.). comparative biomarker profiles of pacritinib, momelotinib, pexidartinib, and ruxolitinib using BioMAP Diversity PLUS panel. European journal of cancer, 69, S136–. http://access.bl.uk/ark:/81055/vdc_100039473461.0x000048